Skip to main content
Oncodesign Precision Medicine Société anonyme (EPA:ALOPM)
France flag France · Delayed Price · Currency is EUR
0.2410
-0.0110 (-4.37%)
Last updated: Nov 11, 2026, 10:48 AM CET

EPA:ALOPM Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
1.81.811.621.418.25
Revenue Growth
-0.62%11.66%14.90%-82.88%-
Gross Profit
-3.598.75-4.89-6.580.69
Operating Income
-6.255.71-7.81-9.94-1.61
Net Income
-6.415.48-7.21-8.09-0.23
Earnings Per Share
-0.340.30-0.40-0.49-0.01
EPS Growth
-----

Revenue by Segment
Chart
Fiscal Year
FY 2025
Period EndingDec '25
Products Annexed Activities
0.16
Taxable Services
0.11
Total
0.26

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
2.912.115.2710.3413.37
Total Debt
6.466.387.588.832.6
Net Cash (Debt)
-3.55-4.27-2.311.5110.77
Net Cash Growth
----85.98%-
Net Cash Per Share
-0.19-0.23-0.130.090.65

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
-199.37%482.81%--8.39%
Operating Margin
-346.94%314.83%-480.86%-703.75%-19.51%
Pretax Margin
-352.03%304.13%-511.87%-697.39%-20.87%
Profit Margin
-355.69%302.27%-444.06%-572.60%-2.80%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22
PE Ratio
-1.36---
Forward PE
-0.21---
PS Ratio
2.554.127.9921.221.42